Skip to main content
Journal of Medicine and Life logoLink to Journal of Medicine and Life
. 2015;8(Spec Iss 4):275–281.

Hepatoprotective effect of Zataria Multiflora Boisson cisplatin-induced oxidative stress in male rat

A Ahmadipour *, F Sharififar **, F Nakhaipour *, M Samanian *, S Karami-Mohajeri *
PMCID: PMC5319274  PMID: 28316744

Abstract

Background: This research aimed to evaluate the protective effects of methanolic extract of Zataria Multiflora Boiss (Z. Multiflora) against hepatic damage induced by cisplatin in male Wistar rats.

Methods: Hepatotoxicity was induced in Wistar male rats by a single intraperitoneal administration of cisplatin, 7 g/ kg body weight. A methanolic extract of Z. Multiflora was administered orally at doses of 50 mg/ kg, 100 mg/ kg, 200 mg/ kg and 400 mg/ kg body weight daily for seven days after being cisplatin-induced. The study included the histopathological examination of the liver sections. The activity of aspartate transaminase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP) were evaluated as markers of liver damage. The superoxide dismutase (SOD), the activity of Catalase (CAT), and glutathione peroxidase (GSH-Px) and malondialdehyde (MDA) and nitric oxide (NO) content in serum were measured as an oxidative stress factor.

Results: The results showed that rat treated with cisplatin resulted in a significant increase in serum activity, AST, ALT and ALP in treated mice. Management with Z. Multiflora reduced the business of these enzymes to nearly normal levels. In parallel with these changes, this extract reduced cisplatin-induced oxidative stress by inhibiting lipid peroxidation and protein carbonylation, and restoring the antioxidant enzyme (SOD, CAT, and GSH-Px) and elevation of the glutathione level.

Conclusion: Biochemical and histological observations showed the hepatoprotective effect was found in a dose-dependent manner in Z. Multiflora methanolic extract. This protective effect can be attributed to the antioxidant compounds.

Keywords: Z. Multiflora, cisplatin, hepatoprotective, liver toxicity, antioxidant activity

Introduction

Cisplatin is one of the anticancer drugs that is frequently used for the treatment of various types of cancers [1,2]. However, dose-dependent hepatotoxicity induced by cisplatin limits the use of this useful drug [3-6]. Although renal cisplatin is recognized as the most important dose-limiting factor, little is known about liver damage caused by cisplatin [7]. The mechanism of alteration in liver function caused by cisplatin was not thoroughly revealed. Scientists believe that the oxidative damage to membrane lipids and other cellular components are an important factor in liver toxicity of cisplatin [8-10]. Cisplatin causes changes in the glutathione (GSH) status and increases lipid Peroxidation (LPO) [11-14]. The primary target for oxidative stress is induced by cisplatin mitochondria, resulting in the loss of mitochondrial protein SH, inhibiting the absorption of calcium, and decreasing mitochondrial membrane potential [15]. Hydrogen peroxide (H2O2), superoxide anion (O2•−) and hydroxyl radicals (OH•) are generated during oxidative stress [16,17]. The other radical producing mechanism is nitric oxide (NO) which reacts with O2•− to form peroxynitrite, a toxic agent to the cellular components [18]. Endogenous antioxidants that prevent the oxidative damage are involved in the superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-PX) [19].

Medicinal plants are the primary source of a vast number of bioactive compounds used for the treatment of many diseases. Due to the presence of the antioxidant compounds such as phenols, flavonoids, tannins, many plants can be very useful in delaying or inhibiting the induction of oxidative stress [20-22]. The effect of these antioxidants as scavengers of free radicals was confirmed in several reports [23-27]. Zataria Multiflora Boiss (Z. Multiflora), belonging to the family Labiatae, is native in Iran and is used traditionally in food, especially in yogurt flavoring, as a stimulant, condiment, carminative [28]. Very high medicinal properties of this plant were reported, such as antioxidant, antimicrobial, analgesic, and anti-inflammatory activity [29]. The methanol extract and essential oil of Z. Multiflora have exhibited the considerable antioxidant effect that was attributed to phenolic compounds found in its extract [29]. This study investigated the protective effects of antioxidant chemistry Z. Multiflora against cisplatin-induced liver damage in male rats.

Materials

In this research, adult male Wistar rats were used. Animals throughout the experiment were fed a standard commercial diet, kept at the room temperature, and held in a 12-hourlight/ 12-hour-dark cycle. All the analyses were performed by the “Guide for Care and Use of Laboratory Animals, DHEW Publication Done (NIH) 85-23, 1985”.

Preparation of plant extracts

Z. Multiflora plants were collected from the mountain of Shiraz city and were authenticated by Professor Fariba Sharififar of Kerman University of Medical Sciences, who has expertise in ethnobotany. Fresh aerial parts of the plants were washed under running water, shaded, and dried at room temperature (25 ± 2°C) for a week. Powder (250 g) was added in 750 ml of petroleum ether and then kept stirring for one night at room temperature. The supernatant extract was filtered, and the remaining plants were dried, the protocol being done with chloroform and then with methanol too. Finally, the methanol extract evaporated at 45°C with a rotary evaporator. The resulted dry powder was collected and stored in a refrigerator at 4°C for further use.

Animal treatment

For the experiment, the animals were classified into five groups (8 rats in each group as it follows: Normal control group received normal saline (10 ml/ kg body weight (b.w.)) by gavage for seven days. The active group received a single intraperitoneal (IP) dose of cisplatin of 7mg/ kg b.w. [30]. Three groups were treated with Z. Multiflora extract at different concentrations (50, 100, 200, and 400 mg/ kg b.w. by gavage) in normal saline (10 ml/ kg b.w.) for 7 consecutive days after a single IP dose of cisplatin. At the end of the therapy, all the rats were anesthetized with petroleum ether. Two ml of blood were taken through a cardiac puncture, and then serum was separated and rapidly frozen at −70°C for later analysis. Subsequent blood sampling, all the animals were killed, and the liver tissue was taken for biochemical analysis and histopathological examination.

Histopathological analysis

A part of the right lobe of the liver was fixed in 10% neutral buffered formalin and processed for embedding in paraffin. Sections of 6µm thickness were cut and stained with hematoxylin and eosin for the evaluation of morphometric analysis and imaging by OLYMPUS photomicroscope.

Serum aminotransferase levels

To assess the damage of cell membrane of hepatocytes, the activity of the liver enzymes alanine transaminase markers (ALT) and aspartate transaminase (AST) were measured by the method described by Reitman and Frankel [31] and alkaline phosphatase (ALP) was based on the method presented by King and Armstrong [32].

Lipid peroxidation assay

The lipid peroxidation was estimated by using Beuge and Bust method [33] based on the measurement of total malondialdehyde (MDA) as the major product of lipid peroxidation.

Protein oxidation

Protein oxidation was measured by estimating the total amount of the carbonyl group according to Levine and et al. method [34].

Reduced glutathione level

Glutathione (GSH) levels of liver were measured by using the modified method of Jollow Kalmanand et al. [35]. 0.5ml of 10% sulphosalicylic acid was added to a mixture of 0.4ml and 0.6ml of distilled water as homogeneous sediment protein. 0.5 ml of the supernatant of the reaction mixture, 4.5 ml and 0.5 ml of 0.5M Tris buffer of 10mm DTNB were mixed and the absorptions were read at 412 nm immediately. GSH content was calculated by using GSH as the standard and expressed as mmol/ of tissue.

Superoxide dismutase (SOD) activity

The total SOD activity was determined according to the method of Sun et al. [36]. It was based on the inhibition of nitro blue tetrazolium (NBT) reduction as a superoxide generator by xanthine-xanthine Oxidase system. The reagent contained 0.067 M Potassium phosphate buffer, pH 7.8, 0.1 M Ethylenediaminetetraacetic acid, and 1.5 mMNBT and the absorbances were read at 560nm. One unit of SOD was defined as the amount of enzyme that inhibited 50% of the reduction of NBT and was expressed asU/ mg protein.

Catalase (CAT) activity

The CAT activity was measured by the method of Johansson and et al. [37]. The reaction mixture contained 50mM phosphate buffer, pH 7.0, and three mM H2O2, and it was recorded spectrophotometrically at 240 nm. One unit of CAT was defined as one nmol of degraded H2O2/ min/ milligram of protein.

Nitric oxide determination

Tissue nitrite (NO2-) and nitrate (NO3-) level were calculated as an indicator of nitric oxide (NO) by Griess reaction method [38]. Total nitrite (nitrite + nitrate) was measured spectrophotometrically at 545 nm after the conversion of nitrate to nitrite by copperized cadmium granules. A standard curve was established with a series of dilutions of sodium nitrite and results were reported as µmol/ gr of tissue.

Protein measurement

The protein concentration was evaluated according to the method of Bradford [39].

Statistical analysis

Data were analyzed by using the commercially available SPSS Software. Data were also analyzed by one-way ANOVA and Post hoc multiple comparison tests. Results were presented as means ± standard error (SEM). P-Values < 0.05 were regarded as statistically significant.

Results and discussion

Histopathological finding

The microscopic study of the liver tissue sections from the control group showed large polygonal cells with eosinophilic cytoplasm and round natural core arranged around the central vein and several hepatic sinuses (Fig. 1). In contrast, the second group received only cisplatin, which revealed obvious histological abnormalities including severe fatty change, central venous sinus congestion, and necrosis mainly around the central vein (Fig. 2). While the third and fourth group received 50 and 100 mg/ kg b.w. of Z. Multiflora methanolic extract along with cisplatin, it showed a regression of the fatty changes in the liver cell cytoplasm (Fig. 3,4). A greater improvement and the scattering of the apoptotic cells were seen at doses of 200 mg/ kgb.w. of Z. Multiflora methanolic extract (Fig. 5). The best results were observed in a dose of 400 mg/ kg b.w. of Z. Multiflora methanolic extract (Fig. 6).

Fig. 1.

Fig. 1

Photomicrographs of liver sections obtained from the normal group

Fig. 2.

Fig. 2

Cisplatin–induced group on the lipid peroxidation of liver tissue in comparison with positive and negative control groups

Fig. 3.

Fig. 3

Effect of Cisplatin + Z. Multiflora (50 mg/ kg) group on the protein oxidation of liver tissue in comparison with positive and negative control groups

Fig. 4.

Fig. 4

Effect of Cisplatin + Z. Multiflora (100 mg/ kg) on the glutathione content of liver tissue as compared to positive and negative control groups

Fig. 5.

Fig. 5

Effect of Cisplatin + Z. Multiflora (200 mg/ kg) group on the nitric oxide content of liver tissue in comparison with positive and negative control groups

Fig. 6.

Fig. 6

Effect of Cisplatin + Z. Multiflora (400 mg/ kg) group on the activity of superoxide dismutase enzyme in comparison with positive and negative control groups

Serum aminotransferase levels

The animals were treated with toxic doses of cisplatin that had markedly elevated values of the serum AST, ALT, and ALP compared to the normal group, indicating acute hepatocellular damage. The effects of the treatment with different doses of Z. Multiflora methanolic extract on serum AST, ALT, and ALP activities after the injection of cisplatin are shown in Table 1. The treatment with Z. Multiflora methanolic extract was continued for seven days after receiving the cisplatin reduced serum activities of AST, ALT, and ALP. The maximum decrease in serum AST, ALT, and ALP activities was observed in rats treated with 400 mg/ kg b.w. of Z. The Multiflora methanolic extract that significantly reduced serum AST, ALT, and ALP activities in the treated group were observed only in the cisplatin-induced group.

Table 1.

Effect of various doses of Z. Multiflora on the activity of the serum aminotransferase enzymes in comparison with positive and negative control groups

Normal Cisplatin Cisplatin + Zm 50 mg/ kg Cisplatin + Zm 100 mg/ kg Cisplatin + Zm 200 mg/ kg Cisplatin + Zm 400 mg/ kg Sig.
AST(IU/ l) 179.97 ± 24.61 414.36 ± 30.40 361.80 ± 37.13 284.08 ± 42.92 246.49 ± 37.49 238.96 ± 45.22 P <0.001
ALT(IU/ l) 59.59 ± 16.25 102.75 ± 16.25 93.48 ± 18.17 86.23 ± 28.08 71.23 ± 9.26 64.86 ± 11.33 P <0.001
ALP(IU/ l) 510.57 ± 39.44 803.38 ± 130.95 788.45 ± 94.92 709.33 ± 92.55 617.59 ± 40.58 582.67 ± 42.79 P <0.001

Lipid peroxidation

Tissue levels of MDA were significantly high in the cisplatin-treated group in comparison with the control group. On the other hand, Z. Multiflora reduced the level of MDA, and the best dose was 50mg/ kg. Results are shown in Fig. 2.

GSH content

GSH levels in the liver of the treated rats with only one injection of cisplatin showed a significant reduction (0.398 mg/ mg protein) compared to the standard group (0.778 mg/ mg protein). The treatment with methanol extracts of Z. Multiflora after the injection of a single dose of cisplatin significantly inhibited the reduction of the GSH level in the liver tissue, and the maximum effective dose was of 400 mg/ kg of methanol extracts.

Antioxidant enzymes activities

The activity of SOD and CAT in the liver of the cisplatin group was of 0.156U/ mg protein, 0.447 micromoles/min/mg protein and was better than the one in the cisplatin-induced group (0.189 U/ mg protein (P < 0.001), 0.731 micromoles/min/mg protein (P < 0.001). The results are shown in Fig. 4 and 5.

Discussion

The hepatotoxicity of cisplatin is one of the major side effects of this drug [40]. Our histopathology findings in the liver tissue of the rat revealed cell degeneration, necrosis, and inflammatory infiltration on the seventh day after the execution of a single dose of cisplatin. Other findings in this study confirmed that the hepatocellular damage is the activity of serum aminotransferase, which was elevated in comparison with the control group.

This study, like other studies, proved the induction of oxidative stress in liver tissue after cisplatin administration in rats [7,12,41-44]. The high dose of cisplatin caused a lipid peroxidation in liver tissue [8,42-47] and reduced the antioxidant enzymes activities, SOD, CAT, and GSH-PX, and GSH level of liver tissue.

Reactive oxygen species and oxidative stress are thought to be a mechanism for cisplatin-induced cellular injury, so treatment and prevention strategies relying on antioxidants can be very helpful in the reduction of the hepatotoxicity side effect of cisplatin. Many studies have been done to establish a balance between oxidant and antioxidant system in cisplatin-treated cases by using a different group of antioxidants [48-51].

Along with other studies, this study also showed the hepatoprotective and antioxidant effects of methanolic extract of Z. Multiflora against cisplatin-induced liver damage in rats. Hepatocellular damage caused by cisplatin improved in groups received a metanolic extract of Z. Multiflora. The methanolic extracts of Z. Multiflora normalized the serum activities of ALT, ALP, AST, SOD, CAT, and GSH-Px, lipid peroxidation, and the GSH content in the liver.

Data from this study fully showed that the Z. Multiflora methanolic extract has a powerful effect on liver protection and the control of the toxicity increases in the serum, after the injection of Cisplatin in the rat in a dose-dependent manner. In addition, the use of this plant extract can be justified in the treatment of various diseases in traditional medicine because of its radical scavenging capacity. The drug profile of the extract on the clinical trials should be further investigated.

Conclusion

Finally, based on this research, we can conclude that the Z. Multiflora methanolic extract causes a general protective effect against liver damage caused by cisplatin. Regarding the content of methionine and antioxidant properties, the protective effect of Z. Multiflora methanolic extract is regarded as a liberal radical scavenger, inhibitor of lipid peroxidation, and factor that decreases the glutathione levels.

References

  • 1.Van Basten J, Koops HS, Sleijfer DT, Pras E, Van Driel M, Hoekstra H. Current concepts about testicular cancer. European Journal of Surgical Oncology (EJSO) 1997;23(4):354–360. doi: 10.1016/s0748-7983(97)90966-5. [DOI] [PubMed] [Google Scholar]
  • 2.Thigpen T, Vance R, Punky L, Khansur T. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Gynecologic Oncology. 1994;55(3):S97–S107. doi: 10.1006/gyno.1994.1347. [DOI] [PubMed] [Google Scholar]
  • 3.Hassan I, Chibber S, Naseem I. Ameliorative effect of riboflavin on the cisplatin-induced nephrotoxicity and hepatotoxicity under photo-illumination. Food and Chemical Toxicology. 2010;48(8):2052–2058. doi: 10.1016/j.fct.2010.05.004. [DOI] [PubMed] [Google Scholar]
  • 4.Zicca A, Cafaggi S, Mariggiò MA, Vannozzi MO, Ottone M, Bocchini V, et al. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. European Journal of Pharmacology. 2002;442(3):265–272. doi: 10.1016/s0014-2999(02)01537-6. [DOI] [PubMed] [Google Scholar]
  • 5.Cersosimo RJ. Hepatotoxicity associated with cisplatin chemotherapy. Annals of Pharmacotherapy. 1993;27(4):438–441. doi: 10.1177/106002809302700408. [DOI] [PubMed] [Google Scholar]
  • 6.Liao Y, Lu X, Lu C, Li G, Jin Y, Tang H. Selection of agents for prevention of cisplatin-induced hepatotoxicity. Pharmacological Research. 2008;57(2):125–131. doi: 10.1016/j.phrs.2008.01.001. [DOI] [PubMed] [Google Scholar]
  • 7.Mansour HH, Hafez HF, Fahmy NM. Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. Journal of Biochemistry and Molecular Biology. 2006;39(6):656. doi: 10.5483/bmbrep.2006.39.6.656. [DOI] [PubMed] [Google Scholar]
  • 8.İşeri S, Ercan F, Gedik N, Yüksel M, Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology. 2007;230(2):256–264. doi: 10.1016/j.tox.2006.11.073. [DOI] [PubMed] [Google Scholar]
  • 9.Elsendoorn T, Weijl N, Mithoe S, Zwinderman A, Van Dam F, De Zwart F, et al. Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2001;498(1):145–158. doi: 10.1016/s1383-5718(01)00278-9. [DOI] [PubMed] [Google Scholar]
  • 10.Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology. 2005;212(2):116–123. doi: 10.1016/j.tox.2005.04.016. [DOI] [PubMed] [Google Scholar]
  • 11.Ganga UK, Kishori B, Reddy PS. Cisplatin and etoposide induce oxidative stress in testicular, hepatic and kidney tissues in male albino mice. Journal of Biology and Earth Sciences. 2013;3(2):B249–B254. [Google Scholar]
  • 12.Kart A, Cigremis Y, Karaman M, Ozen H. Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in the rabbit. Experimental and Toxicologic Pathology. 2010;62(1):45–52. doi: 10.1016/j.etp.2009.02.066. [DOI] [PubMed] [Google Scholar]
  • 13.Omar HA, Mohamed WR, Arafa E-SA, Shehata BA, El Sherbiny GA, Arab HH, et al. Hesperidin alleviates cisplatin-induced hepatotoxicity in rats without inhibiting its antitumor activity. Pharmacological Reports. 2015 doi: 10.1016/j.pharep.2015.09.007. [DOI] [PubMed] [Google Scholar]
  • 14.Cagin YF, Erdogan MA, Sahin N, Parlakpinar H, Yatayan A, Apolat A, et al. Protective Effects of Apocynin on Cisplatin-induced Hepatotoxicity In Rats. Archives of Medical Research. 2015 doi: 10.1016/j.arcmed.2015.08.005. [DOI] [PubMed] [Google Scholar]
  • 15.Saad SY, Najjar TA, Alashari M. Role of non‐selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin‐induced nephrogonadal toxicity in rats. Clinical and Experimental Pharmacology and Physiology. 2004;31(12):862–867. doi: 10.1111/j.1440-1681.2004.04127.x. [DOI] [PubMed] [Google Scholar]
  • 16.Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M, et al. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. Journal of Applied Toxicology. 2004;24(1):47–52. doi: 10.1002/jat.945. [DOI] [PubMed] [Google Scholar]
  • 17.Fadıllıoğlu E, Erdoğan H. Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacological Research. 2003;47(4):317–322. doi: 10.1016/s1043-6618(03)00010-0. [DOI] [PubMed] [Google Scholar]
  • 18.Akyol Ö, Herken H, Uz E, Fadıllıoǧlu E, Ünal S, Söǧüt S, et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients: the possible role of oxidant/antioxidant imbalance. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2002;26(5):995–1005. doi: 10.1016/s0278-5846(02)00220-8. [DOI] [PubMed] [Google Scholar]
  • 19.Yagmurca M, Erdogan H, Iraz M, Songur A, Ucar M, Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clinica Chimica Acta. 2004;348(1):27–34. doi: 10.1016/j.cccn.2004.03.035. [DOI] [PubMed] [Google Scholar]
  • 20.Ahmad N, Abbasi BH, Fazal H, Khan MA, Afridi MS. Effect of reverse photoperiod on in vitro regeneration and piperine production in Piper nigrum L. Comptes Rendus Biologies. 2014;337(1):19–28. doi: 10.1016/j.crvi.2013.10.011. [DOI] [PubMed] [Google Scholar]
  • 21.Gill SS, Tuteja N. Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants. Plant Physiology and Biochemistry. 2010;48(12):909–930. doi: 10.1016/j.plaphy.2010.08.016. [DOI] [PubMed] [Google Scholar]
  • 22.Madrigal-Santillán E, Madrigal-Bujaidar E, Álvarez-González I, Sumaya-Martínez MT, Gutiérrez-Salinas J, Bautista M, et al. Review of natural products with hepatoprotective effects. World Journal of Gastroenterology: WJG. 2014;20(40):14787. doi: 10.3748/wjg.v20.i40.14787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ruberto G, Baratta MT. Antioxidant activity of selected essential oil components in two lipid model systems. Food chemistry. 2000;69(2):167–174. [Google Scholar]
  • 24.Cai Y, Luo Q, Sun M, Corke H. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sciences. 2004;74(17):2157–2184. doi: 10.1016/j.lfs.2003.09.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pourmorad F, Hosseinimehr S, Shahabimajd N. Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants. African Journal of Biotechnology. 2006;5(11) [Google Scholar]
  • 26.Katalinic V, Milos M, Kulisic T, Jukic M. Screening of 70 medicinal plant extracts for antioxidant capacity and total phenols. Food Chemistry. 2006;94(4):550–557. [Google Scholar]
  • 27.Surveswaran S, Cai Y-Z, Corke H, Sun M. Systematic evaluation of natural phenolic antioxidants from 133 Indian medicinal plants. Food Chemistry. 2007;102(3):938–953. [Google Scholar]
  • 28.Sharififar F, Moshafi M, Mansouri S, Khodashenas M, Khoshnoodi M. In vitro evaluation of antibacterial and antioxidant activities of the essential oil and methanol extract of endemic Zataria multiflora Boiss. Food control. 2007;18(7):800–805. [Google Scholar]
  • 29.Sharififar F, Derakhshanfar A, Dehghan-Nudeh G, Abbasi N, Abbasi R, Gharaei RR, et al. In vivo antioxidant activity of Zataria multiflora Boiss essential oil. Pakistan Journal of Pharmaceutical Sciences. 2011;24(2):221–225. [PubMed] [Google Scholar]
  • 30.Yildirim Z, Sogut S, Odaci E, Iraz M, Ozyurt H, Kotuk M, et al. Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacological Research. 2003;47(2):149–156. doi: 10.1016/s1043-6618(02)00282-7. [DOI] [PubMed] [Google Scholar]
  • 31.Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxyacetic and glutamic pyruvic transaminases. 1957 doi: 10.1093/ajcp/28.1.56. [DOI] [PubMed] [Google Scholar]
  • 32.King EJ AAR. Calcium phosphorus and phosphatase. 1988 [Google Scholar]
  • 33.Buege JA, Aust SD. Microsomal lipid peroxidation. Methods in Enzymology. 1978;52:302–310. doi: 10.1016/s0076-6879(78)52032-6. [DOI] [PubMed] [Google Scholar]
  • 34.Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods in Enzymology. 1994;233:346–357. doi: 10.1016/s0076-6879(94)33040-9. [DOI] [PubMed] [Google Scholar]
  • 35.Jollow D, Mitchell JN, Gillette J. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974;11(15):1–169. doi: 10.1159/000136485. [DOI] [PubMed] [Google Scholar]
  • 36.Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry. 1988;34(3):497–500. [PubMed] [Google Scholar]
  • 37.Johansson LH, Borg LH. A spectrophotometric method for determination of catalase activity in small tissue samples. Analytical Biochemistry. 1988;174(1):331–336. doi: 10.1016/0003-2697(88)90554-4. [DOI] [PubMed] [Google Scholar]
  • 38.Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clinical Chemistry. 1990;36(8):1440–1443. [PubMed] [Google Scholar]
  • 39.Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 1976;72(1):248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  • 40.Lucas K, Hensel D. Fertility preservation options for women treated for cancer. Nursing for women’s health. 2014;18(2):138–147. doi: 10.1111/1751-486X.12110. [DOI] [PubMed] [Google Scholar]
  • 41.Yilmaz HR, Sogut S, Ozyurt B, Ozugurlu F, Sahin S, Isik B, et al. The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester. Toxicology and Industrial Health. 2005;21(1-2):67–73. doi: 10.1191/0748233705th216oa. [DOI] [PubMed] [Google Scholar]
  • 42.Martins N, Santos N, Curti C, Bianchi M, Santos A. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. Journal of Applied Toxicology. 2008;28(3):337–344. doi: 10.1002/jat.1284. [DOI] [PubMed] [Google Scholar]
  • 43.Pratibha R, Sameer R, Rataboli PV, Bhiwgade DA, Dhume CY. Enzymatic studies of cisplatin-induced oxidative stress in hepatic tissue of rats. European Journal of Pharmacology. 2006;532(3):290–293. doi: 10.1016/j.ejphar.2006.01.007. [DOI] [PubMed] [Google Scholar]
  • 44.Lu Y, Cederbaum AI. Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicological Sciences. 2006;89(2):515–523. doi: 10.1093/toxsci/kfj031. [DOI] [PubMed] [Google Scholar]
  • 45.Liu J, Liu Y, Habeebu SS, Klaassen CD. Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicology and Applied Pharmacology. 1998;149(1):24–31. doi: 10.1006/taap.1997.8325. [DOI] [PubMed] [Google Scholar]
  • 46.Jun LY, Hao T, Ping JY. Study of toxic effects on hearing, kidney and liver of mice induced by an anticancer agent of cisplatin and their mechanisms [J]. Chinese Pharmacological Bulletin. 2004;1:022. [Google Scholar]
  • 47.Hong KO, Hwang JK, Park K-K, Kim SH. Phosphorylation of c-Jun N-terminal Kinases (JNKs) is involved in the preventive effect of xanthorrhizol on cisplatin-induced hepatotoxicity. Archives of Toxicology. 2005;79(4):231–236. doi: 10.1007/s00204-004-0623-7. [DOI] [PubMed] [Google Scholar]
  • 48.Rana M, Ahmed H. Effect of Vitamin C on the Hepatotoxicity Induced by Cisplatin in Rats. J Sci. 2012;23(2):23–33. [Google Scholar]
  • 49.Afifi M, Abbas A. Effects of reduced glutathione and vitamin c on cisplatin-induced hepatotoxicity in rats. Egyptian Journal of Biochemistry and Molecular Biology. 2011;29(1) [Google Scholar]
  • 50.Omar HE-DM, Ahmed EA, Abdel-Ghaffar S, Mohammed S, Nasser AY. Hepatoprotective effects of vitamin C, DPPD, and L-cysteine against cisplatin-induced oxidative stress in male rats. Journal of Biology and Earth Sciences. 2012;2(1):B28–B36. [Google Scholar]
  • 51.Bhattacharyya S, Mehta P. The hepatoprotective potential of Spirulina and vitamin C supplementation in cisplatin toxicity. Food & Function. 2012;3(2):164–169. doi: 10.1039/c1fo10172b. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medicine and Life are provided here courtesy of SC Jurnalul pentru Medicina si Viata SRL

RESOURCES